Creditori Commerciali Cambiamento Data
Amarin USD 40.43M 21.63M 2026-09
Ardelyx USD 33.66M 4.75M 2026-09
Baxter International USD 1.02B 10M 2026-09
Bayer EUR 6.71B 314M 2026-09
BioCryst Pharmaceuticals USD 14.58M 3.12M 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Emergent BioSolutions USD 112.2M 500K 2023-12
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Halozyme Therapeutics USD 33.55M 9.94M 2026-09
Insmed USD 84.3M 9.75M 2026-09
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.32B 94M 2026-09
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Moderna USD 167M 6M 2026-06
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 4.07B 511M 2026-09
PTC Therapeutics USD 41.59M 1.14M 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Teva Pharmaceutical Industries USD 2.55B 170M 2026-09
United Therapeutics USD 520.2M 22.4M 2026-09
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09